• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

AstraZeneca, CCT Partner to Conduct COVID-19 Vaccine Clinical Trials in Arizona

by Jasmine Pennic 11/12/2020 Leave a Comment

AstraZeneca, CCT Partner to Conduct COVID-19 Vaccine Clinical Trials in Arizona

What You Should Know: - AstraZeneca and CCT announce a partnership to conduct COVID-19 vaccine clinical trials in Arizona with 1,500 participants. CCT Research (CCT), a leader in community-based, embedded clinical research, today announced its partnership with AstraZeneca to advance COVID-19 research. Together with local healthcare providers, CCT will facilitate clinical trials for the AZD1222 COVID-19 VACCINE,
Read More

Peregrine Ventures Launches $300M VC Fund for Late-Stage Life Science Companies

by Fred Pennic 11/10/2020 Leave a Comment

Peregrine Ventures Launches $300M VC Fund for Late Stage Life Science Companies

What You Should Know: - Israeli-based Peregrine Ventures launches a new $300 million venture capital fund named Peregrine Growth to focus on late-stage life science companies. - Peregrine Growth will invest $20 to $30 million per funding round, with a strong emphasis on companies that are on the verge of an IPO or M&A.  Peregrine Ventures, one of Israel’s premier venture capital firms focused on the life sciences, today announced the launch of a new growth fund, Peregrine
Read More

FDA Awards Eli Lilly Emergency Use Authorization for Antibody to Treat COVID-19

by Jasmine Pennic 11/10/2020 Leave a Comment

FDA Awards Eli Lilly Emergency Use Authorization for Antibody to Treat COVID-19

What You Should Know: - Eli Lilly is awarded Emergency Use Authorization (EUA) by the FDA for its monoclonal antibody for the treatment of recently diagnosed, mild to moderate COVID-19 in high-risk patients. -  U.S. government will allocate 300,000 doses of bamlanivimab to high-risk patients, with no out-of-pocket costs for the medication. The U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for Eli Lilly and Company's (NYSE: LLY)
Read More

Cytek Biosciences Raises $120M To Expand Spectral Cell Analysis Systems

by Jasmine Pennic 11/05/2020 Leave a Comment

Cytek Biosciences Raises $120M To Expand Spectral Cell Analysis Systems

What You Should Know: - Cytek Biosciences raises 120M in Series D funding – underscoring the company’s growing momentum and significant contributions to the field of cell analysis. - Cytek, whose innovative flow cytometers represent the first big technological leap in flow cytometry in decades, is currently transitioning into a complete solution provider for the cell analysis market. - This most recent funding round accelerates this transition and helps the company expand support for
Read More

Mammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At Scale

by Fred Pennic 10/30/2020 Leave a Comment

Mammoth Lands 2 Partnerships to Use CRISPR to Solve COVID19 Testing Shortage

What You Should Know: - Mammoth Biosciences signs agreements with MilliporeSigma and Hamilton company targeting commercialization of high-throughput CRISPR-based SARS CoV-2 Test. - These partnerships will help Mammoth bring a turnkey CRISPR-based sample-to-answer solution for commercial laboratories to enable a multi-fold increase in a testing capacity. Mammoth Biosciences, Inc., announced that it has signed agreements with MilliporeSigma and Hamilton Company targeting
Read More

Mission Bio Launches Single-Cell Multi-Omics System for Precision Cancer Therapies

by Jasmine Pennic 10/30/2020 Leave a Comment

Mission Bio Launches Single-Cell Multi-Omics System for Precision Cancer Therapies

What You Should Know: - Mission Bio launches industry’s first and only single-cell multi-omics platform, is announcing the launch of its most comprehensive instrument to-date, to save the industry billions of dollars in drug development costs and bring life-saving treatments to market at least six months faster. - Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that
Read More

Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD

by Jasmine Pennic 10/29/2020 Leave a Comment

Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD

What You Should Know: - Today, Medidata, TriNetX, and Datavant announced a partnership to accelerate the use of real-world data (RWD) to power clinical research. - Linking RWD, which is data not collected during the specific context of a clinical trial, can help improve understanding of the long-term safety and efficacy of new therapies.  Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to
Read More

CVS Health Adds 1,000 COVID-19 Rapid-Result Testing at Retail Pharmacy Locations

by Fred Pennic 10/28/2020 Leave a Comment

CVS Health Adds 1,000 COVID-19 Rapid-Result Testing at Retail Pharmacy Locations

What You Should Know: - CVS Health announced plans to expand COVID-19 testing services by offering rapid-result testing at select CVS Pharmacy locations and through the company’s return to work COVID-19 testing solution, Return Ready. - Rapid-result tests can help to slow the spread of the virus, especially when combined with other preventive measures including social distancing and “mask-wearing” because it provides patients with the opportunity for a quick diagnosis, appropriate
Read More

LabCorp Launches Fully Integrated Clinical Trial Platform to Streamline Drug Development Process

by Fred Pennic 10/20/2020 Leave a Comment

LabCorp Launches Fully Integrated Clinical Trial Platform to Streamline Drug Development Process

What You Should Know: - LabCorp launches fully integrated clinical trial platform to streamline the drug development process featuring - The new clinical trial platform will deliver dramatic reductions in patient and study site administrative tasks, improve trial resiliency, and maintain study continuity through the use of the company’s data, technology, and direct-to-patient outreach capabilities.   Global life sciences company LabCorp today announced new capabilities that
Read More

Ori Biotech Lands $30M for Cell and Gene Therapy Manufacturing Platform

by Fred Pennic 10/15/2020 Leave a Comment

Biotech Startup Ori Biotech Lands $30M for Cell and Gene Therapy Manufacturing Platform

What You Should Know: - Biotech startup Ori Biotech raises $30M in Series A funding to scale its cell and gene therapy (CGT) manufacturing platform. - Ori Biotech helps pharmaceutical and biotech companies develop and manufacture cell and gene therapies. Its patented technology aims to reduce the manufacturing cost of these life-saving treatments by up to 80%, allowing them to be more widely accessible for patients. Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 77
  • Go to page 78
  • Go to page 79
  • Go to page 80
  • Go to page 81
  • Interim pages omitted …
  • Go to page 90
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |